Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8

Author： Porquet David   Casadesús Gemma   Bayod Sergi   Vicente Alberto   Canudas Anna   Vilaplana Jordi   Pelegrí Carme   Sanfeliu Coral   Camins Antoni   Pallàs Mercè   Valle Jaume  

Publisher： Springer Publishing Company

ISSN： 0161-9152

Source： AGE, Vol.35, Iss.5, 2013-10, pp. : 1851-1865

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Gene mutation increases risk of late-onset Alzheimer’s disease

By  

Personalized Medicine, Vol. 4, Iss. 1, 2007-02 ,pp. : 7-10

Future Medicine

Access to resources Recommend Favorite

Dietary arachidonic acid: a Janus face actor in brain and Alzheimer’s disease?

By Pinchaud Katleen   Maguin-Gaté Katy   Olivier Jean-Luc  

OCL (Oilseeds, Crops, fats & Lipids), Vol. 25, Iss. 4, 2018-08 ,pp. : D406-D406

Edp Sciences

Access to resources Recommend Favorite

Pain and Alzheimer’s Disease

By  

Gerontology, Vol. 46, Iss. 5, 2000-08 ,pp. : 235-241

Karger

Access to resources Recommend Favorite

Somatotype in Alzheimer’s Disease

By  

Gerontology, Vol. 53, Iss. 4, 2007-03 ,pp. : 200-204

Karger

Access to resources Recommend Favorite

The Reduced Release of GH by GHRH in 8 Subjects Aged 65–69 Years Is Augmented Considerably by Rivastigmine, a Drug for Alzheimer’s Disease

By  

Gerontology, Vol. 49, Iss. 3, 2003-04 ,pp. : 191-195

Karger

Access to resources Recommend Favorite